loadpatents
name:-0.0003809928894043
name:-0.015591859817505
name:-0.0015988349914551
Octamer, Inc. Patent Filings

Octamer, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Octamer, Inc..The latest application filed is for "method for inhibition of retroviral replication".

Company Profile
0.16.0
  • Octamer, Inc. - Berkeley CA
  • Octamer, Inc. - Mill Valley CA
  • Octamer, Inc. - DE
  • Octamer, Incorporated - Mill Valley CA
  • Octamer, Inc. - Sausalito CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for inhibition of retroviral replication
Grant 6,316,495 - Kun , et al. November 13, 2
2001-11-13
Methods for treating inflammation, inflammatory diseases, arthritis and stroke using pADPRT inhibitors
Grant 6,303,629 - Kun October 16, 2
2001-10-16
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
Grant 6,017,958 - Kun , et al. January 25, 2
2000-01-25
Methods of treating cancer with aromatic nitro and nitroso compounds and their metabolites
Grant 6,004,978 - Kun , et al. December 21, 1
1999-12-21
Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity
Grant 5,922,775 - Kun , et al. July 13, 1
1999-07-13
Synergistic compositions useful as anti-tumor agents
Grant 5,877,185 - Kun , et al. March 2, 1
1999-03-02
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents, anti-retroviral agents and anti-tumor agents
Grant 5,753,674 - Kun , et al. May 19, 1
1998-05-19
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
Grant 5,736,576 - Kun , et al. April 7, 1
1998-04-07
6-amino-1,2-benzopyrones useful for treatment of viral diseases
Grant 5,583,155 - Kun , et al. December 10, 1
1996-12-10
5-Iodo-6-amino-1,2-Benzopyrones and their metabolites useful as cytostatic agents
Grant 5,519,053 - Kun , et al. May 21, 1
1996-05-21
Specific inactivators of "retroviral" (asymmetric) zinc fingers
Grant 5,516,941 - Kun , et al. May 14, 1
1996-05-14
5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
Grant 5,484,951 - Kun , et al. January 16, 1
1996-01-16
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
Grant 5,482,975 - Kun , et al. January 9, 1
1996-01-09
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54
Grant 5,473,074 - Kun , et al. December 5, 1
1995-12-05
Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
Grant 5,464,871 - Kun , et al. November 7, 1
1995-11-07
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
Grant 5,262,564 - Kun , et al. November 16, 1
1993-11-16
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed